These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1911360)

  • 21. Unexpected serological results in haemolytic disease of the newborn.
    Lowes BC
    J Med Lab Technol; 1970 Oct; 27(4):475-7. PubMed ID: 4992539
    [No Abstract]   [Full Text] [Related]  

  • 22. Serological and prognostic significance of partial absorption anti-human globulin test for incomplete Rh antibodies.
    Srinivasan K; Bhatia HM
    Indian J Med Res; 1973 Mar; 61(3):402-5. PubMed ID: 4202050
    [No Abstract]   [Full Text] [Related]  

  • 23. [Allo-immunization against antigens from non-D blood groups. Value of detection].
    Mannessier L; Goudemand M; Delecour M
    Lille Med; 1980 Mar; 25(3):90-3. PubMed ID: 6768941
    [No Abstract]   [Full Text] [Related]  

  • 24. Red-cell antibodies in pregnancy: evidence overturned.
    Clark DA
    Lancet; 1996 Feb; 347(9000):485-6. PubMed ID: 8596262
    [No Abstract]   [Full Text] [Related]  

  • 25. Mononuclear phagocyte assays, autoanalyzer quantitation and IgG subclasses of maternal anti-RhD in the prediction of the severity of haemolytic disease in the fetus before 32 weeks gestation.
    Garner SF; Wiener E; Contreras M; Nicolini U; Kochenour N; Letsky E; Rodeck CH
    Br J Haematol; 1992 Jan; 80(1):97-101. PubMed ID: 1536816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemolytic disease of the newborn caused by anti-Lan antibody.
    Smith DS; Stratton F; Johnson T; Brown R; Howell P; Riches R
    Br Med J; 1969 Jul; 3(5662):90-2. PubMed ID: 5790273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of severity of haemolytic disease of newborn by monocyte monolayer assay.
    Dhingra-Kumar N; Duguid JK; Bromilow IM
    Indian J Med Res; 1995 Aug; 102():71-6. PubMed ID: 8834817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of the severity of rhesus haemolytic disease of the newborn by an ADCC assay.
    Urbaniak SJ; Greiss MA; Crawford RJ; Fergusson MC
    Lancet; 1981 Jul; 2(8238):142-3. PubMed ID: 6113496
    [No Abstract]   [Full Text] [Related]  

  • 29. Editorial: Management of maternal isoimmunization.
    Med J Aust; 1974 Oct; 2(15):547-8. PubMed ID: 4214982
    [No Abstract]   [Full Text] [Related]  

  • 30. The epidemiology of severe haemolytic disease of the newborn.
    Kinnock S; Liley AW
    N Z Med J; 1970 Feb; 71(453):76-83. PubMed ID: 4986220
    [No Abstract]   [Full Text] [Related]  

  • 31. Intra-uterine transfusion.
    Falconer B
    Radiography; 1969 Dec; 35(420):295-6. PubMed ID: 4982649
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative evaluation of the direct Coombs' test and the erythrocytic gelatin test in the diagnosis of hemolytic disease of the newborn].
    Mikhaĭlova AA
    Probl Gematol Pereliv Krovi; 1979 Feb; 24(2):46-8. PubMed ID: 106380
    [No Abstract]   [Full Text] [Related]  

  • 33. Rhesus haemolytic disease.
    Whittle MJ
    Arch Dis Child; 1992 Jan; 67(1 Spec No):65-8. PubMed ID: 1536591
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prenatal diagnosis and prevention of hemolytic disease of newborn].
    Fischer K
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():64-9. PubMed ID: 8374293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An explanation of the failure of the direct antiglobulin test to detect erythrocyte sensitization in ABO haemolytic disease of the newborn and observations on pinocytosis of IgG anti-A antibodies by infant (cord) red cells.
    Voak D; Williams MA
    Br J Haematol; 1971 Jan; 20(1):9-23. PubMed ID: 5099693
    [No Abstract]   [Full Text] [Related]  

  • 36. [Obstetrical supervision of fetomaternal blood group incompatibilities].
    Chavinie J; Poissonnier MH
    Soins Gynecol Obstet Pueric Pediatr; 1983; (27-28):21-3. PubMed ID: 6558875
    [No Abstract]   [Full Text] [Related]  

  • 37. [Early determination of ABO incompatibility. Catamnestic studies of 141 pregnancies with suspicion or clinical evidence of ABO incompatibility].
    Kröger E; Scherbening G
    Munch Med Wochenschr; 1969 Nov; 111(46):2388-92. PubMed ID: 5394823
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prenatal diagnosis and therapy of hemolytic disease of the newborn].
    Fischer K; Poschmann A; Hellwege HH; Kitschke HJ; Carstensen M; Sprotte C; Schreer I
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):167-70. PubMed ID: 4010672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rhesus erythroblastosis, monitoring and treatment].
    Siebers JW; Rasenack R; Hillemanns HG
    Zentralbl Gynakol; 1985; 107(20):1226-42. PubMed ID: 3934880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rhesus haemolytic disease of the newborn and its prevention.
    Clarke C
    Br J Haematol; 1982 Dec; 52(4):525-35. PubMed ID: 6182898
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.